News

Why Is Liquidia Stock Trading Higher On Tuesday?
Liquidia Q2 sales hit $8.84 million after Yutrepia launch; PH-ILD study shows stable tolerability and improved walking ...
A Look at Allogene Therapeutics's Upcoming Earnings Report
Analysts expect Allogene Therapeutics to report an earnings per share (EPS) of $-0.27. Allogene Therapeutics bulls will hope ...